Skip to main content
. 2023 Apr 12;14:1074242. doi: 10.3389/fimmu.2023.1074242

Figure 2.

Figure 2

Correlation between various clinical factors and expression of FADSs in BC. (A, B) The mRNA expression levels of FADS1/2 in different breast cancer clinical stages, respectively. (C, D) The mRNA expression levels of FADS1/2 in different breast cancer M stages, respectively. (E–H) The mRNA expression levels of FADS1/4/7/8 in different breast cancer N stages (lymph node metastasis in BC), respectively. * P < 0.05, ** P < 0.01, *** P < 0.001.